0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......


Basic View | Expanded View
 Showing 21-32 of 32 Articles
Original Investigation 
Juan M. Pascual, MD, PhD; Peiying Liu, PhD; Deng Mao, BS; Dorothy I. Kelly, MA; Ana Hernandez, MS; Min Sheng, PhD; Levi B. Good, PhD; Qian Ma, MD, PhD; Isaac Marin-Valencia, MD, MS; Xuchen Zhang, MD; Jason Y. Park, MD, PhD; Linda S. Hynan, PhD; Peter Stavinoha, PhD; Charles R. Roe, MD; Hanzhang Lu, PhD
Includes: Supplemental Content

Importance  Disorders of brain metabolism are multiform in their mechanisms and manifestations, many of which remain insufficiently understood and are thus similarly treated. Glucose transporter type I deficiency (G1D) is commonly associated with seizures and with electrographic spike-waves. The G1D syndrome has long been attributed to energy ...

Original Investigation 
Dominic Holland, PhD; Linda Chang, MD; Thomas M. Ernst, PhD; Megan Curran; Steven D. Buchthal, PhD; Daniel Alicata, MD; Jon Skranes, MD; Heather Johansen; Antonette Hernandez; Robyn Yamakawa; Joshua M. Kuperman, PhD; Anders M. Dale, PhD
Includes: Supplemental Content

Importance  The very early postnatal period witnesses extraordinary rates of growth, but structural brain development in this period has largely not been explored longitudinally. Such assessment may be key in detecting and treating the earliest signs of neurodevelopmental disorders.

Objective  To assess structural growth trajectories and ...

Original Investigation 
Angel C. Y. Mak, PhD; Clive R. Pullinger, PhD; Ling Fung Tang, PhD; Jinny S. Wong, BS; Rahul C. Deo, MD, PhD; Jean-Marc Schwarz, PhD; Alejandro Gugliucci, MD, PhD; Irina Movsesyan, BS; Brian Y. Ishida, PhD; Catherine Chu, BS; Annie Poon, BS; Phillip Kim, MD; Eveline O. Stock, MD; Ernst J. Schaefer, MD; Bela F. Asztalos, PhD; Joseph M. Castellano, PhD; Tony Wyss-Coray, PhD; Jacque L. Duncan, MD; Bruce L. Miller, MD; John P. Kane, MD, PhD; Pui-Yan Kwok, MD, PhD; Mary J. Malloy, MD
Includes: Supplemental Content

Importance  The identification of a patient with a rare form of severe dysbetalipoproteinemia allowed the study of the consequences of total absence of apolipoprotein E (apoE).

Objectives  To discover the molecular basis of this rare disorder and to determine the effects of complete absence of apoE ...

Review 
David S. Warner, MD; Michael L. James, MD; Daniel T. Laskowitz, MD; Eelco F. Wijdicks, MD, PhD
Includes: Supplemental Content

Importance  Research to improve outcomes from acute central nervous system (CNS) injury has progressed little, although limited examples (eg, induced hypothermia for out-of-hospital ventricular fibrillation cardiac arrest and birth asphyxia and tissue plasminogen activator for ischemic stroke) have proved that it is possible to favorably alter outcome....

Case Report/Case Series 
Mathilde Renaud, MD; Mathieu Anheim, MD, PhD; Erik-Jan Kamsteeg, PhD; Martial Mallaret, MD; Fanny Mochel, MD, PhD; Sascha Vermeer, MD, PhD; Nathalie Drouot, MSc; Jean Pouget, MD; Claire Redin, PhD; Emmanuelle Salort-Campana, MD; Hubertus P. H. Kremer, MD, PhD; Corien C. Verschuuren-Bemelmans, MD; Jean Muller, PhD; Hans Scheffer, PhD; Alexandra Durr, MD, PhD; Christine Tranchant, MD; Michel Koenig, MD, PhD

Importance  ANO10 mutations have been reported to cause a novel form of autosomal recessive cerebellar ataxia (ARCA). Our objective was to report 9 ataxic patients carrying 8 novel ANO10 mutations to improve the delineation of this form of ARCA and provide genotype-phenotype correlation.

Observations  The ANO10...

Editorial 
Philip B. Gorelick, MD, MPH
Hypertension affects more than two-thirds of US adults 60 years or older,1 and control is considered by some to be the “crown jewel” of stroke prevention. Despite mounting epidemiologic and mechanistic evidence linking raised blood pressure (BP) to cognitive decline or dementia, uncertainty remains about the benefit of lowering BP ...
Original Investigation 
Rebecca F. Gottesman, MD, PhD; Andrea L. C. Schneider, MD, PhD; Marilyn Albert, PhD; Alvaro Alonso, MD, PhD; Karen Bandeen-Roche, PhD; Laura Coker, PhD; Josef Coresh, MD, PhD; David Knopman, MD; Melinda C. Power, ScD; Andreea Rawlings, MS; A. Richey Sharrett, MD, DrPH; Lisa M. Wruck, PhD; Thomas H. Mosley, PhD
Includes: Supplemental Content

Importance  Hypertension is a treatable potential cause of cognitive decline and dementia, but its greatest influence on cognition may occur in middle age.

Objective  To evaluate the association between midlife (48-67 years of age) hypertension and the 20-year change in cognitive performance.

Design, Setting, and Participants...

Original Investigation 
Kevin S. King, MD; Julia Kozlitina, PhD; Roger N. Rosenberg, MD; Ronald M. Peshock, MD; Roderick W. McColl, PhD; Christine K. Garcia, MD, PhD
Includes: Supplemental Content

Importance  Telomere length has been associated with dementia and psychological stress, but its relationship with human brain size is unknown.

Objective  To determine if peripheral blood telomere length is associated with brain volume.

Design, Setting, and Participants  Peripheral blood leukocyte telomere length and brain volumes ...

Viewpoint 
Michael T. Melia, MD; Paul M. Lantos, MD; Paul G. Auwaerter, MD
The spirochete Borrelia burgdorferi may afflict skin, heart, joints, and the central or peripheral nervous system. This agent of Lyme disease, perhaps because of its varied presentations, is often raised as the cause of headache, fatigue, and subjective neurocognitive dysfunction. For clinicians who trained in the 20th century when the ...
In this issue of Archives, McKeon et al1 report that 10 of 81 patients with stiff-man syndrome from the Mayo Clinic in Rochester, Minnesota, had serum and/or cerebrospinal fluid IgG antibodies that bound to fixed, permeabilized HEK293 cells (an immortalized human kidney line) that had been transfected to express the ...
Topics: autoantibodies
Original Contribution  FREE
Ross W. Paterson, MRCP; Charles C. Torres-Chae, MPA; Amy L. Kuo, MS, RN, GNP; Tim Ando, BA; Elizabeth A. Nguyen, BS; Katherine Wong, BS; Stephen J. DeArmond, MD, PhD; Aissa Haman, MD; Paul Garcia, MD; David Y. Johnson; Bruce L. Miller, MD; Michael D. Geschwind, MD, PhD

Objectives To identify the misdiagnoses of patients with sporadic Jakob-Creutzfeldt disease (sCJD) during the course of their disease and determine which medical specialties saw patients with sCJD prior to the correct diagnosis being made and at what point in the disease course a correct diagnosis was made.

Design...

Original Contribution  FREE
Yafei Huang, PhD; Rachel Potter, BA; Wendy Sigurdson, MSN; Tom Kasten, PhD; Rose Connors, BA; John C. Morris, MD; Tammie Benzinger, MD; Mark Mintun, MD; Tim Ashwood, PhD; Mats Ferm, PhD; Samantha L. Budd, PhD; Randall J. Bateman, MD
Includes: Supplemental Content

Objectives To investigate dynamic changes in human plasma β-amyloid (Aβ) concentrations, evaluate the effects of aging and amyloidosis on these dynamics, and determine their correlation with cerebrospinal fluid (CSF) Aβ concentrations.

Design A repeated plasma and CSF sampling study.

Setting The Washington University School of Medicine in St ...

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal